[HTML][HTML] Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide,
characterized by liver fatty acid accumulation and fibrosis, not due to excessive alcohol …
characterized by liver fatty acid accumulation and fibrosis, not due to excessive alcohol …
[HTML][HTML] Effects of chromium picolinate supplementation on cardiometabolic biomarkers in patients with type 2 diabetes mellitus: A randomized clinical trial
AT Talab, H Abdollahzad, SM Nachvak… - Clinical nutrition …, 2020 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is a serious public health problem accompanies with
several complications. This study was conducted to evaluate the effects of chromium …
several complications. This study was conducted to evaluate the effects of chromium …
Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with …
Objective: There is a promising perspective regarding the potential effect of resveratrol in
preventing and treating metabolic disturbances similar to that of calorie restriction. The aim …
preventing and treating metabolic disturbances similar to that of calorie restriction. The aim …
[HTML][HTML] Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver
E Aigner, G Weiss, C Datz - World journal of hepatology, 2015 - ncbi.nlm.nih.gov
Elevated iron stores as indicated by hyperferritinemia with normal or mildly elevated
transferrin saturation and mostly mild hepatic iron deposition are a characteristic finding in …
transferrin saturation and mostly mild hepatic iron deposition are a characteristic finding in …
[HTML][HTML] Lycopene modulates pathophysiological processes of non-alcoholic fatty liver disease in obese rats
M Róvero Costa, J Leite Garcia… - Antioxidants, 2019 - mdpi.com
Background: The higher consumption of fat and sugar are associated with obesity
development and its related diseases such as non-alcoholic fatty liver disease (NAFLD) …
development and its related diseases such as non-alcoholic fatty liver disease (NAFLD) …
[HTML][HTML] Randomized clinical trial: bergamot citrus and wild cardoon reduce liver steatosis and body weight in non-diabetic individuals aged over 50 years
Background: Non-alcoholic fatty liver disease is the most common cause of liver-related
morbidity and mortality in the world. However, no effective pharmacological treatment for this …
morbidity and mortality in the world. However, no effective pharmacological treatment for this …
Therapeutic effects of resveratrol on nonalcoholic fatty liver disease through inflammatory, oxidative stress, metabolic, and epigenetic modifications
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing around the world,
in association with the progressive elevation in overweight and obesity. The accumulation of …
in association with the progressive elevation in overweight and obesity. The accumulation of …
Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover …
NC Li, C Cui, J Xu, MT Mi, J Wang, Y Qin - The American Journal of Clinical …, 2024 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) has become a growing public health
problem worldwide. However, there is still lack of effective treatment strategies except …
problem worldwide. However, there is still lack of effective treatment strategies except …
[HTML][HTML] Effects of the Mixture of Cichorium intybus L. and Cinnamomum zeylanicum on Hepatic Enzymes Activity and Biochemical Parameters in Patients with …
The prevalence of nonalcoholic fatty liver disease (NAFLD) as a metabolic disorder affecting
the liver function is rapidly increasing and there is a need to develop new and more efficient …
the liver function is rapidly increasing and there is a need to develop new and more efficient …
The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial
M Bahrami, M Cheraghpour, S Jafarirad… - … therapies in medicine, 2020 - Elsevier
Objectives Many factors implicated in the pathogenesis of non-alcoholic fatty liver disease
(NAFLD) are including oxidative stress, insulin resistance and abnormal production of …
(NAFLD) are including oxidative stress, insulin resistance and abnormal production of …